ArticleHospital pharmacy2022

Safety and Efficacy Analysis of Apixaban Compared to Heparins in Hospitalized Non-Critically Ill COVID-19 Patients.

Daniel Appiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.